KITE-222

· Kite, A Gilead Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KITE-222, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]